Reset filters
  • 9 January 2006

ICAAC: Nevirapine’s manufacturer examines rates of liver toxicity in key study, finds once daily dose equally safe at lower CD4 count

Read the article
  • 6 January 2006

ICAAC: Dividing Triomune tablets may result in inadequate doses for small children; liquid best

Read the article
  • 6 January 2006

ICAAC: TMC114 shows further promise in second POWER study

Read the article
  • 5 January 2006

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

Read the article
  • 5 January 2006

ICAAC: Viral load between six to 18 months predicts longer-term success of HIV therapy

Read the article
  • 4 January 2006

ICAAC: Pilot study shows dual protease inhibitor regimen as safe and effective as traditional two class HIV therapy

Read the article
  • 4 January 2006

ICAAC: New treatment for lipid problems shows promise in HIV patients

Read the article
  • 4 January 2006

ICAAC: TB patients with good CD4 cell counts can safely defer HIV treatment

Read the article
  • 20 December 2005

ICAAC: Early trials involving new GSK protease inhibitor have encouraging results

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.